Parker Institute for Cancer Immunotherapy

Modernizing Regulatory Pathways for Faster Access to CGT Breakthroughs – Parker Institute for Cancer Immunotherapy

Parker Institute for Cancer Immunotherapy shared a post on X:

”How do we modernize regulatory pathways so today’s CGT breakthroughs reach patients at the pace of science? At an FDA roundtable, Carl June, Director of the PICI Center at Penn Medicine, and Crystal Mackall, Director of the PICI Center at Stanford Medicine joined FDA and were among the voices calling for bold changes to ensure novel therapies reach patients faster. A few key takeaways:

  • Speed saves lives
  • Barriers to nonprofit innovation must fall
  • The U.S. can lead—if we evolve

Tune into the recording.”

cancer Carl June Crystal Mackall FDA OncoDaily Oncology Parker Institute for Cancer Immunotherapy Penn Medicine Stanford Medicine